Obituaries

Last Name

Frank J. Ayd Jr., 1920–2008 (PDF 250Kb)

In 1953 Dr. Ayd became the first clinician in the United States authorized by the FDA to study chlorpromazine in patients. In 1955 he published the results, initiating the modern era of psychopharmacology in this country.

Henri Begleiter, 1935-2006 (PDF 53Kb)

Henri Begleiter, Ph.D., was a leader in the fields of neuroscience, alcoholism and genetics. Dr. Beigleiter was instrumental in organizing the largest study in the world focused on the genetics of alcoholism.

Wagner H. Bridger (PDF 79Kb)

Wagner H. Bridger, M.D., published over 100 papers, was a founding member of the Society of Biological Psychiatry and President of the Society in 1988 and Editor of the journal from 1992-1997.

John J. Burns, 1920-2007 (PDF 47Kb)

John J. Burns, Ph.D., supported basic science research more than any other pharmaceutical executive, both within his company as well as in the academic community. One of his most outstanding contributions was the establishment of the Roche Institute of Molecular Biology.

C Jelleff Carr, 1910-2005 (PDF 43Kb)

C. Jelleff Carr Ph.D., a founding father of the International Society of Regulatory Toxicology and Pharmacology, died on February 15, 2005.

Jonathan O. Cole, 1925-2009 (PDF 174Kb)

Dr. Cole, a founder and early ACNP president, received the first Paul Hoch Distinguished Service Award. As CINP secretary, 1965-1969, his contributions were recognized with the coveted Pioneers in Psychopharmacology award.

Erminio Costa, 1924-2009 (PDF 219Kb)

Dr. Costa's enthusiasm and ability to translate scientific hypotheses into successful experiments were contagious for all his collaborators—more than 300 in 60 years.

Samuel Eiduson, 1918-2007 (PDF 52Kb)

Samuel Eiduson, Ph.D., one of neurochemistry's early pioneers, was the prime mover of the four authors of 'Biochemistry and Behaviour', which became the first major text for many subsequent investigators.

User Name:
Password:

Forgot your user name or password?
Remember me.